Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma

作者: S-G. Wu , C-H. Gow , C-J. Yu , Y-L. Chang , C-H. Yang

DOI: 10.1183/09031936.00167407

关键词:

摘要: Malignant pleural effusions (MPEs) are often observed in lung cancer, especially adenocarcinoma. Epidermal growth factor receptor (EGFR) gene mutations usually detected The purpose of the present study was to investigate EGFR mutation rate MPEs Between June 2005 and December 2006, 136 from adenocarcinoma were collected for detection. In addition, between April 2001 November 2004, 91 surgically resected specimens patients without assessed mutation. significantly higher with than (68.4% versus 50.5%). not associated sex, smoking history, age or cancer stage. By multivariate analysis, an <65 yrs, never smoking, Eastern Cooperative Oncology Group performance status 0-1, a longer overall survival MPEs. malignant related had epidermal whom taken. tyrosine kinase inhibitors may be treatment choice east Asia.

参考文章(44)
Ming-Szu Hung, Cheng-Ta Yang, Ying-Huang Tsai, Shaw-Wei Leu, Mei-Yi Wu, Chin-Kuo Lin, Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions. Chang Gung medical journal. ,vol. 29, pp. 373- 379 ,(2006)
L. F. Brown, M. Detmar, K. Claffey, J. A. Nagy, D. Feng, A. M. Dvorak, H. F. Dvorak, Vascular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine EXS. ,vol. 79, pp. 233- 269 ,(1997) , 10.1007/978-3-0348-9006-9_10
Harvey I. Pass, Lung cancer : principles and practice Lippincott Williams & Wilkins. ,(1996)
Yuichi Dai, Yukio Morishita, Kentaro Mase, Nakako Sato, Eiichi Akaogi, Toshio Mitsui, Masayuki Noguchi, Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas. Cancer. ,vol. 90, pp. 258- 263 ,(2000) , 10.1002/1097-0142(20000825)90:4<258::AID-CNCR10>3.0.CO;2-F
Ximing Tang, Hisayuki Shigematsu, B. Nebiyou Bekele, Jack A. Roth, John D. Minna, Waun Ki Hong, Adi F. Gazdar, Ignacio I. Wistuba, EGFR Tyrosine Kinase Domain Mutations Are Detected in Histologically Normal Respiratory Epithelium in Lung Cancer Patients Cancer Research. ,vol. 65, pp. 7568- 7572 ,(2005) , 10.1158/0008-5472.CAN-05-1705
Adi F. Gazdar, Shinichi Toyooka, Kazunori Tsukuda, Mitsune Tanimoto, Masahiro Tabata, Kouichi Ichimura, Masaaki Yano, Toshihide Tsuda, Hisayuki Shigematsu, Hiroshi Date, Kunitoshi Tomii, Nobuyoshi Shimizu, Hiroshi Ueoka, Motoi Aoe, Masaki Tokumo, Katsuyuki Kiura, The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers Clinical Cancer Research. ,vol. 11, pp. 1167- 1173 ,(2005)
Junichi Soh, Shinichi Toyooka, Keisuke Aoe, Hiroaki Asano, Syuji Ichihara, Hideki Katayama, Akio Hiraki, Katsuyuki Kiura, Motoi Aoe, Yoshifumi Sano, Kazuro Sugi, Nobuyoshi Shimizu, Hiroshi Date, Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer. International Journal of Cancer. ,vol. 119, pp. 2353- 2358 ,(2006) , 10.1002/IJC.22190
Nack Cheon Bae, Myung Hwa Chae, Myung Hoon Lee, Kyung Mee Kim, Eung Bae Lee, Chang Ho Kim, Tae-In Park, Sung Beom Han, Sanghoon Jheon, Tae Hoon Jung, Jae Yong Park, EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients Cancer Genetics and Cytogenetics. ,vol. 173, pp. 107- 113 ,(2007) , 10.1016/J.CANCERGENCYTO.2006.10.007
Federico Cappuzzo, Fred R. Hirsch, Elisa Rossi, Stefania Bartolini, Giovanni L. Ceresoli, Lynne Bemis, Jerry Haney, Samir Witta, Kathleen Danenberg, Irene Domenichini, Vienna Ludovini, Elisabetta Magrini, Vanesa Gregorc, Claudio Doglioni, Angelo Sidoni, Maurizio Tonato, Wilbur A. Franklin, Lucio Crino, Paul A. Bunn, Marileila Varella-Garcia, Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer Journal of the National Cancer Institute. ,vol. 97, pp. 643- 655 ,(2005) , 10.1093/JNCI/DJI112
Jin-Yuan Shih, Chien-Hung Gow, Pan-Chyr Yang, EGFR Mutation Conferring Primary Resistance to Gefitinib in Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 353, pp. 207- 208 ,(2005) , 10.1056/NEJM200507143530217